Seeing Is Believing
Currently out of the existing stock ratings of Uy Ear, 18 are a HOLD (28.57%), 45 are a BUY (71.43%).
Analyst Uy Ear works at MIZUHO with a stock forecast success ratio of 24.33% fulfilled within 29.5 days on average.
Uy Ear’s has documented 117 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 28-Feb-2024.
Analyst best performing recommendations are on ACAD (ACADIA PHARMACEUTICALS).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 1/2/2024. The price target of $8 was fulfilled within 45 days with a profit of $4.57 (133.24%) receiving and performance score of 29.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
17
$7.41 (77.27%)
16
1 months 1 days ago
2/15 (13.33%)
$6.59 (63.30%)
58
Buy
16
$6.41 (66.84%)
8
1 months 1 days ago
1/9 (11.11%)
$5.59 (53.70%)
102
Hold
11
$1.41 (14.70%)
6
1 months 1 days ago
2/4 (50%)
$0.59 (5.67%)
55
Buy
11
$1.41 (14.70%)
10
3 months 8 days ago
2/8 (25%)
$8.4 (323.08%)
89
Buy
10
$0.41 (4.28%)
45
4 months 16 days ago
1/3 (33.33%)
$7.89 (373.93%)
106
Which stock is Uy Ear is most bullish on?
Which stock is Uy Ear is most reserved on?
What Year was the first public recommendation made by Uy Ear?